Literature DB >> 19394718

[What is happening with the new diabetes mellitus drugs?].

Eduard Diogène Fadini, Dolores Rodríguez Cumplido.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19394718      PMCID： PMC7021986          DOI： 10.1016/j.aprim.2008.12.006

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  5 in total

1.  Finding new treatments for diabetes--how many, how fast... how good?

Authors:  David M Nathan
Journal:  N Engl J Med       Date:  2007-02-01       Impact factor: 91.245

2.  Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

3.  Three new drugs for type 2 diabetes.

Authors: 
Journal:  Drug Ther Bull       Date:  2008-07

Review 4.  Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

Authors:  Renee E Amori; Joseph Lau; Anastassios G Pittas
Journal:  JAMA       Date:  2007-07-11       Impact factor: 56.272

Review 5.  Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C L Lerch
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.